Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Multiple Sclerosis – Unmet Need – Unmet Need – Relapsing Forms of Multiple Sclerosis (US/EU)
An increasing number of clinically unique immunomodulatory disease-modifying therapies (DMTs) are approved for the treatment of relapsing forms of multiple sclerosis (MS), the most prevalent form…
Cervical Dystonia – Executive Insights – Cervical Dystonia | Executive Insights | US/EU5/China
Cervical dystonia (CD), is a rare neurological disorder that mostly affects middle-aged adults, with an average age of symptom onset of 50 years. Given the rarity of the condition and symptomatic…
Spasticity – Executive Insights – Adult Spasticity | Executive Insights | US/EU5/China
Spasticity is characterized by an increase in muscle tone and is highly prevalent among patients diagnosed with some neurological conditions (e.g., stroke, multiple sclerosis [MS], spinal cord…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Executive Insights – Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Executive Insights | US/EU5 | 2022
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder caused by inflammation and demyelination of the peripheral nerves characterized by weakness associated with loss of…
